Photoelectrochemical aptasensor for thrombin based on Au-rGO-CuS as signal amplification elements

Nucleic acid aptamer-based biosensors and their application in thrombin analysis

Thrombin is a multifunctional serine protease that plays an important role in coagulation and anticoagulation processes. Aptamers have been widely applied in biosensors due to their high specificity, low cost and good biocompatibility. This review summarizes recent advances in thrombin quantification using aptamer-based biosensors. The primary focus is optical sensors and electrochemical sensors, along with their applications in thrombin analysis and disease diagnosis.

Recent Progresses in Development of Biosensors for Thrombin Detection

Thrombin is a serine protease with an essential role in homeostasis and blood coagulation. During vascular injuries, thrombin is generated from prothrombin, a plasma protein, to polymerize fibrinogen molecules into fibrin filaments. Moreover, thrombin is a potent stimulant for platelet activation, which causes blood clots to prevent bleeding. The rapid and sensitive detection of thrombin is important in biological analysis and clinical diagnosis. Hence, various biosensors for thrombin measurement have been developed. Biosensors are devices that produce a quantifiable signal from biological interactions in proportion to the concentration of a target analyte. An aptasensor is a biosensor in which a DNA or RNA aptamer has been used as a biological recognition element and can identify target molecules with a high degree of sensitivity and affinity. Designed biosensors could provide effective methods for the highly selective and specific detection of thrombin. This review has attempted to provide an update of the various biosensors proposed in the literature, which have been designed for thrombin detection. According to their various transducers, the constructions and compositions, the performance, benefits, and restrictions of each are summarized and compared.

A Visible-Light-Active CuS/MoS2/Bi2WO6 Aptamer Sensitively Detects the Non-Steroidal Anti-Inflammatory Drug Diclofenac

Diclofenac is a non-steroidal, anti-inflammatory drug and is clinically used for the treatment of osteoarthritis, non-articular rheumatism, etc. This research aimed to demonstrate the creation of an upgraded photoelectrochemical (PEC) aptamer sensor for detecting diclofenac (DCF) with high sensitivity. In this work, photoactive materials and bio-identification components served as visible-light-active CuS/MoS₂/Bi₂WO₆ heterostructures and aptamers, respectively. CuS and MoS₂/Bi₂WO₆ were combined to improve photocurrent responsiveness, which helped the structure of PEC aptasensors. Additionally, the one-pot synthesis of CuS/MoS₂/Bi₂WO₆ was ecologically beneficial. With these optimizations, the photocurrent response of aptamer/CS/CuS/MoS₂/Bi₂WO₆ exhibited linearity between 0.1 and 500 nM DCF. The detection limit was 0.03 nM (S/N = 3). These results suggest that the PEC sensing technique might produce an ultra-sensitive sensor with high selectivity and stability for DCF detection.

Current progress in aptamer-based sensing tools for ultra-low level monitoring of Alzheimer's disease biomarkers

Alzheimer's disease (AD) as common late-life dementia is pathologically associated with the irreversible and progressive disorder, misfolding, deposition, and accumulation of the brain proteins. Especially, the formation of fibrous amyloid plaques by aggregation of amyloid-β peptides is the pathological cause of this neurologic disorder disease. Besides, tau protein isoforms destabilize the microtubule filaments through post-translational modifications and induce nerve cells' death. Amyloid-β peptides and tau proteins are considered as the critical symptom and reliable molecular biomarkers for the early diagnosis of AD. AD is characterized by impaired thinking proficiencies, cognitive decline, memory loss, and behavioral disability. Since there is no efficacious therapy for AD at present, the development of precise sensing tools for the early diagnosis of this disease is essential and crucial. Aptamer-based biosensors (aptasensors) have acquired utmost importance in the field of AD healthcare, due to excellent sensitivity and specificity, ease-of-use, cost-effectiveness, portability, and rapid assay time. Here, we highlight the recent developments and novel perspectives in the field of aptasensor design to quantitatively monitor the AD biomarkers. Finally, some results are represented to achieve a promising viewpoint for introducing the novel aptasensor test kits in the future.

Photoelectrochemical aptasensing for thrombin based on exonuclease III-assisted recycling signal amplification and nanoceria enzymatic strategy

In the present work, a capture DNA (c-DNA) was immobilized on the TNA/g-C₃N₄ to develop a sensitive and selective TNA/g-C₃N₄/c-DNA photoelectrochemical aptasensor for determining thrombin. With the aid of the specific recognition of anti-thrombin aptamer towards thrombin, ingenious design of hairpin DNA, and exonuclease III-assisted recycling signal amplification, more nanoceria could be assembled on the TNA/g-C₃N₄/c-DNA to form TNA/g-C₃N₄/nanoceria in the presence of thrombin. Due to the oxidase-mimic catalytic efficiency of nanoceria and the oxygen consumption for glucose oxidation, the photoexcited electrons at the conduction band of g-C₃N₄ could be well transferred to that of TNA under visible light irradiation, resulting in the increase of the photocurrent of TNA/g-C₃N₄/nanoceria, and the increase value of photocurrent had a linear relationship with the concentration of thrombin under the optimal conditions. So, the constructed TNA/g-C₃N₄/c-DNA photoelectrochemical aptasensor exhibited a satisfactory quantitative range from 0.01 pM to 0.5 nM, low detection limit with 3.4 fM for thrombin determination, and was applied for the human serum analysis successfully with RSD of less than 4.8% and the recovery between 95% and 113%.

Selective and sensitive visible-light-prompt photoelectrochemical sensor of paracetamol based on Bi2WO6 modified with Bi and copper sulfide

Paracetamol (PA) is a ubiquitous non-steroidal anti-inflammatory drug, mainly used to treat headaches, arthritis and osteoarthritis and other diseases. In this work, a novel label free photoelectrochemical (PEC) sensor based on Bi-CuS/Bi2WO6 has been developed for the detection of PA, which was fabricated by a simple two-step hydrothermal process. It was found that Bi-CuS/Bi2WO6 with a CuS/Bi2WO6 heterojunction and surface plasmon resonance (SPR) effect of Bi possesses enhanced charge transfer and absorption wavelengths under visible light, particularly when compared to pristine Bi2WO6 films, thus producing an increase in the observed photocurrent. The photocurrent was increased after adding PA. And the photocurrent increment was linear with PA concentration in the range from 0.01-60 μM with a detection limit of 2.12 nM. Moreover, the PEC sensor also exhibited high anti-interference property and acceptable stability. In the present study, a Bi-CuS/Bi2WO6 photoelectrode is considered a promising candidate for carrying out PEC analysis.